Navigation Links
ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM)
Date:11/12/2007

EXTON, Pa., Nov. 12 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMEA) has granted orphan drug designation for CAMVIA for the prevention of cytomegalovirus (CMV) disease in patients with impaired cell-mediated immunity. The EMEA's "Orphan Medicinal Product Designation" is designed to promote the development of drugs which may provide significant benefit to patients suffering from rare diseases identified as "life-threatening or very serious conditions."

Under EMEA guidelines, Orphan Medicinal Product Designation provides 10 years of potential market exclusivity if the product candidate is approved for marketing in the European Union. Orphan status also permits EMEA assistance in optimizing the candidate's clinical development through participation in designing the clinical protocol and preparing the marketing application. Additionally, a drug candidate designated by the EMEA as an Orphan Medicinal Product may qualify for a reduction in regulatory fees as well as a European Union-funded research grant. Finally, when a Pediatric Investigation Plan is completed, an additional two years of exclusivity could be granted for a product with orphan medicinal product designation.

"We are very pleased to receive orphan designation for CAMVIA from the EMEA," commented Thierry Darcis, M.D., ViroPharma's vice president and general manager, Europe. "This designation clearly recognizes the potential to address great unmet medical needs with CAMVIA as we work to maximize the global value of the drug. This designation from the EMEA adds additional momentum as we continue to develop CAMVIA for transpl
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. ViroPharma to Present at the Maxim Group First Annual Growth Conference
2. ViroPharma to Present at the UBS Global Life Sciences Conference
3. ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results
4. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
5. DaVita Receives Civil Complaint
6. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
7. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
8. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
9. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
10. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
11. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... The Entertainment Industries Council, Inc. ( EIC ... and recognition activities for thousands of entertainment and news ... recovery. On July 24, 2014, at 8pm, the new ... resources with a special mention of the Substance Abuse ... at the end of the show. , ...
(Date:7/22/2014)... UK (PRWEB) July 22, 2014 The ... over the past few years, owing to novel medical ... with BoNTs in the aging societies where physical appearance ... led by one player, current competitors, new companies and ... biosimilars. As biosimilar BoNTs will put the price of ...
(Date:7/22/2014)... Kathleen Doheny HealthDay Reporter ... uterus with a minimally invasive procedure known as morcellation carries ... study pinpoints the likelihood more clearly. Twenty-seven of every ... at the time of the procedure, researchers found, with the ... Surgeons performing a hysterectomy with morcellation use a power ...
(Date:7/22/2014)... release is available in French . ... diagnosed with depression need to step out for a cigarette ... a mood disorder. And those who have the hardest time ... than they are actually aware of. , Those insights were ... Nicotine & Tobacco Research by a team of researchers ...
(Date:7/22/2014)... 2014 5i Sciences, a medical technology ... of Molly Coye, M.D., M.P.H. to a role as ... authority on the market introduction of innovative technologies that ... will advise on strategies for building a successful commercial ... Dr. Coye is currently the Chief Innovation Officer ...
Breaking Medicine News(10 mins):Health News:ABC’s BLACK BOX Spotlights Mental Health and Available Resources in Upcoming Episode 2Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 2Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 3Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 4Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 2Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 3Health News:Extra exercise helps depressed smokers kick the habit faster 2Health News:5i Sciences Announces Appointment of a Senior Healthcare Consultant and Successful Financing 2
... say , MONDAY, Aug. 17 (HealthDay News) -- The first ... has been identified by U.S. researchers. , The new marker ... a T -- in a segment of DNA near the ... They found it by studying the DNA of 1,671 people ...
... First ever-activist toolkit included with an e-book using interactive iPhone technology. ... 17 Former Vermont Governor and DNC Chairman Emeritus Howard Dean ... empower grassroots activism. Dean has teamed up with Vermont-based progressive publisher ... REAL HEALTHCARE REFORM: How We Can Achieve Affordable Medical Care for ...
... , SANTA MONICA, Calif., Aug. 17 Cord Blood ... cell preservation company ( http://www.cord b lood-america.com ... to families nationwide and internationally, said today that its 10Q filing ... of 2009 shows a significantly improved balance sheet. , , ...
... , ... it’s designed to give prospective patients an idea of what the future can hold. Dr. ... plastic surgery in Dallas a view of what they think would look best for ... room. , ...
... ... ... 17, 2009 -- SuperSlow® Zone of Greater Houston has opened its doors to ... 200 provides a one-on-one efficient, effective workout in a cool (68°), studio environment with state-of-the-art ...
... ... databases enable researchers to quickly and effectively use these invaluable resources. , ... Seattle WA (PRWEB) August 17, 2009 -- ... National Cancer Institute,s Cancer Genome Anatomy Project, or CGAP. The Madeline 2.0 Pedigree Drawing ...
Cached Medicine News:Health News:Genetic Discovery May Improve Hepatitis C Treatment 2Health News:Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate. 2Health News:Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate. 3Health News:Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate. 4Health News:Cord Blood America Says Balance Sheet Significantly Strengthened in 2009 2Health News:Cord Blood America Says Balance Sheet Significantly Strengthened in 2009 3Health News:Dr. Jack P. Gunter Offers 3D Imaging for Dallas, Texas Plastic Surgery Patients 2Health News:Dr. Jack P. Gunter Offers 3D Imaging for Dallas, Texas Plastic Surgery Patients 3Health News:Dr. Jack P. Gunter Offers 3D Imaging for Dallas, Texas Plastic Surgery Patients 4Health News:SuperSlow Zone Opens in Bunker Hill Village 2Health News:New Online Tutorials for Madeline 2.0 and CGAP from OpenHelix 2Health News:New Online Tutorials for Madeline 2.0 and CGAP from OpenHelix 3
(Date:7/22/2014)... The number of people overdosing from opioid ... Twenty-three percent of the workforce has misused prescription painkillers, ... Health, making opioid use a serious threat to employee ... the correct dosage with a valid prescription, subtle impairment ... National Safety Council released a guide for employers, ...
(Date:7/22/2014)... , July 22, 2014  A central ... a SynCardia temporary Total Artificial Heart ... Strong Memorial Hospital with the Freedom® portable driver ... Fontana, a 64-year-old retiree from a Syracuse ... He managed the condition with medications, an implantable ...
(Date:7/22/2014)... PHILADELPHIA ,  July 22, 2014 /PRNewswire/ ... business of Thomson Reuters , the world,s ... and professionals, today announced Cortellis Clinical ... database, marked an industry-first milestone with the ... thus providing pharmaceutical professionals with greater and ...
Breaking Medicine Technology:5 things employers should know about prescription painkiller use 25 things employers should know about prescription painkiller use 3'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 2'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 3Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 2Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 3
... Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading ... a letter dated January 18, 2012 from The Nasdaq Stock ... from the Company,s Board of Directors effective January 4, 2012, ... Nasdaq,s requirement that its audit committee consists of at least ...
... Ind., Jan. 24, 2012 Elanco, the animal health ... LLY ), today announced that Lilly has signed an ... company specializing in the development and commercialization of innovative ... egg, and meat production. Feed enzymes are naturally occurring ...
Cached Medicine Technology:Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee Requirement 2Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen Corp. 2Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen Corp. 3Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen Corp. 4
... AMS 650™ and 600M™ malleable penile prostheses ... those with limited dexterity. These implants are ... patient to position them in an erect ... penis rigid enough for sexual intercourse and ...
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort....
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort....
... Freedom leg bags are part of ... versatile line of leg bags, kits, ... varied needs of our customers. These ... sizes, and constructed of 100% latex-free ...
Medicine Products: